Edition:
India

Pulse Biosciences Inc (PLSE.OQ)

PLSE.OQ on NASDAQ Stock Exchange Capital Market

18.71USD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$18.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
53,967
52-wk High
$39.50
52-wk Low
$9.83

Chart for

About

Pulse Biosciences, Inc., formerly Electroblate, Inc., is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $270.91
Shares Outstanding(Mil.): 14.33
Dividend: --
Yield (%): --

Financials

BRIEF-South Korea's SK Innovation plans to produce batteries in Hungary -media

* Plans to build new battery production unit in Komarom, northwest Hungary - Hungary's state news agency MTI cites environmental protection document published by the city hall of Komarom in northwest Hungary

29 Nov 2017

BRIEF-Pulse Biosciences Inc reports qtrly loss per share $‍0.52​

* Pulse Biosciences Inc - qtrly loss per share $‍0.52​ Source text for Eikon: (http://bit.ly/2AiM76K) Further company coverage:

08 Nov 2017

BRIEF-Pulse Biosciences announces transition of board of directors

* Pulse Biosciences announces transition of board of directors, extends appreciation to retiring members and welcomes new board members

03 Nov 2017

BRIEF-Pulse Biosciences announces $30 million private placement

* Pulse Biosciences - ‍entered into stock purchase agreement for purchase of 2 million shares of company's common stock at a price of $15.02 per share​ Source text for Eikon: Further company coverage:

25 Sep 2017

BRIEF-Pulse Biosciences announces withdrawal and planned resubmission of 510(k) application for the PulseTxTM System

* Pulse Biosciences Inc - "‍remain confident" in ability to obtain a 510(k) clearance for PulseTx System and more broadly for Nano-Pulse Stimulation​

11 Sep 2017

Earnings vs. Estimates

No consensus analysis data available.